Gallstone-Induced vs. Non-Biliary Acute Pancreatitis: Clinical and Management Differences
Bệnh nhân nữ, 45 tuổi, nhập viện vì đau thượng vị
lan ra sau lưng kèm nôn ói. Xét nghiệm ghi nhận amylase máu tăng cao (700
U/L), phù hợp với chẩn đoán viêm tụy cấp trên lâm sàng điển hình. Chẩn đoán
hình ảnh (CT và MRI bụng) xác định viêm tụy cấp mức độ trung bình–nặng, có tụ
dịch quanh tụy nhưng chưa ghi nhận hoại tử hay biến chứng tại chỗ. Bệnh nhân
có nhiều sỏi nhỏ trong túi mật, đường mật không sỏi, men gan (AST/ALT) tăng
nhẹ (200 U/L), bilirubin TP/TT lần lượt là 160/90 µmol/L, chưa có dấu hiệu
suy tạng trên lâm sàng và xét nghiệm. 1. Làm thế nào để ứng dụng các đặc điểm lâm sàng, men gan và hình ảnh học nhằm xác định nhanh nguyên nhân viêm tụy cấp do sỏi mật và phân biệt với các nguyên nhân khác như rượu hoặc tăng triglyceride? 2. Trong trường hợp viêm tụy cấp do sỏi mật, cần áp dụng tiêu chí nào để xác định thời điểm chỉ định ERCP cấp cứu so với quản lý hỗ trợ đơn thuần? 3. Dựa vào nguy cơ tái phát sau khi sỏi mật đã tự thoát, cần triển khai kế hoạch gì để phòng ngừa hiệu quả viêm tụy cấp tái phát ở người chưa được cắt túi mật? 4. Cần ứng dụng kiến thức nào để đánh giá tiên lượng và nguy cơ biến chứng lâu dài ở viêm tụy cấp do sỏi so với các nguyên nhân khác như rượu hoặc tăng lipid máu? 5. Làm thế nào để lựa chọn và triển khai chiến lược theo dõi sau xuất viện nhằm tối ưu hoá kết quả điều trị và phòng ngừa tái phát cho viêm tụy cấp do sỏi mật đã được ổn định? |
1. Diagnostic Distinctions of
Gallstone-Induced Acute Pancreatitis Versus Other Etiologies
Gallstone-induced acute
pancreatitis (GSP) in adults without comorbidities is characterized by a
distinct clinical, laboratory, and imaging profile that differentiates it from
other etiologies such as alcohol-induced, hypertriglyceridemia-induced, and idiopathic
acute pancreatitis (AP). Accurate and early identification of the biliary
etiology is essential, as it directly impacts both acute management and
long-term recurrence prevention.
Clinical and Laboratory Features
GSP typically presents
in older adults, with a female predominance, reflecting the epidemiology of
cholelithiasis. The clinical presentation is similar to other forms of AP,
with acute onset of severe, persistent epigastric pain radiating to the back,
often accompanied by nausea and vomiting. However, a history of prior
biliary colic, known gallstones, or recent right upper quadrant pain increases
the likelihood of a biliary etiology.[1-3]
Laboratory evaluation
is critical for both diagnosis and etiologic differentiation. While
elevations in serum amylase and lipase are diagnostic for AP, they do not
distinguish between etiologies. The most specific laboratory marker for
GSP is a marked elevation in alanine aminotransferase (ALT) greater than 150
U/L within 48 hours of symptom onset, which has a positive predictive value
exceeding 85% and a specificity up to 97% for biliary pancreatitis.[4-6] Additional
liver biochemistry abnormalities, including elevated aspartate aminotransferase
(AST), gamma-glutamyl transferase (GGT), alkaline phosphatase, and direct
bilirubin, are more common in GSP due to transient or persistent biliary
obstruction.[3][6] In
contrast, these findings are less pronounced or absent in alcohol- or
hypertriglyceridemia-induced AP, where other risk factors (e.g., heavy alcohol
use, triglycerides >1000 mg/dL) predominate.[3]
Imaging Features
Imaging is
indispensable for confirming the diagnosis and identifying the
etiology. Transabdominal ultrasonography is the first-line imaging
modality, with a sensitivity exceeding 95% for gallstones in uncomplicated
cases, though sensitivity drops below 80% in the setting of AP due to bowel gas
and ileus.[7] The specificity
remains high, and the presence of gallstones or biliary sludge is a key
distinguishing feature. For common bile duct (CBD) stones, ultrasonography
is less sensitive (50–80%) but highly specific (up to 95%).[7] Endoscopic
ultrasonography (EUS) and magnetic resonance cholangiopancreatography (MRCP)
are more sensitive for detecting small stones or biliary sludge and are
recommended when the diagnosis remains uncertain after initial evaluation.[7]
Computed tomography (CT) is less sensitive for gallstones but is valuable for assessing the severity of pancreatitis and identifying local complications. Recent studies have identified specific CT features associated with GSP, including the presence of gallbladder stones, the "choledochal ring sign" (suggestive of a stone in the distal CBD), increased liver attenuation, and the absence of duodenal thickening. A nomogram combining clinical and CT features has demonstrated high diagnostic accuracy for biliary etiology in AP, with an area under the curve of 0.94.[8]
2. Initial Management Strategies:
Gallstone-Induced Versus Non-Biliary Acute Pancreatitis
The initial management
of GSP in adults without comorbidities is distinguished from non-biliary AP by
the need for early identification and management of biliary obstruction or
cholangitis, and by the requirement for definitive source control via cholecystectomy.
Supportive Care Principles
Supportive care is the
cornerstone of management for all AP etiologies. This includes prompt,
goal-directed intravenous fluid resuscitation (typically 5–10 mL/kg/h of
lactated Ringer’s solution), early initiation of enteral nutrition (oral
feeding as soon as tolerated, even within 24 hours), effective pain control
(usually intravenous opioids), and close monitoring for complications.[9] Overly
aggressive hydration should be avoided, especially in patients at risk for
fluid overload, but this is less of a concern in otherwise healthy
adults. Prophylactic antibiotics are not recommended unless there is clear
evidence of infection (e.g., cholangitis, infected necrosis).[9-10]
Etiology-Specific Interventions in
Gallstone-Induced AP
The management of GSP
diverges from non-biliary AP in several key respects:
Assessment for
persistent biliary obstruction or cholangitis is critical. Clinical
features (fever, jaundice, hypotension), laboratory findings (elevated
bilirubin, transaminases), and imaging (dilated CBD, visible stones) guide this
assessment. The ACG and American Gastroenterological Association (AGA)
guidelines, as well as recent reviews, emphasize that urgent endoscopic
retrograde cholangiopancreatography (ERCP) is indicated only in patients with
GSP who have evidence of cholangitis or persistent biliary obstruction (e.g.,
rising bilirubin, persistent jaundice, or imaging evidence of a retained
stone).[1][9][11] In
the absence of these features, routine or early ERCP does not improve outcomes
and is not recommended.[12-15]
Definitive management
of the gallstone source is essential to prevent recurrence. The ACG and
AGA both recommend that, in patients with mild GSP (i.e., without organ failure
or local complications), laparoscopic cholecystectomy should be performed during
the index admission, ideally within 24–48 hours of clinical stabilization, and
certainly before discharge.[1][9][11][16] This
approach dramatically reduces the risk of recurrent biliary events, including
recurrent pancreatitis, cholecystitis, and biliary colic, with studies showing
recurrence rates of up to 18% if cholecystectomy is delayed.[1][16-18] Intraoperative
cholangiography may be performed to assess for retained CBD stones, with
postoperative or intraoperative ERCP reserved for those with confirmed
choledocholithiasis.[11]
For patients with
moderately severe or severe GSP (i.e., with persistent organ failure, necrosis,
or peripancreatic collections), cholecystectomy should be delayed until the
acute inflammatory process has resolved, typically several weeks after the
initial episode, to reduce operative risk.[1][16][19] In
these cases, interval cholecystectomy is performed after resolution of
collections or at 6–8 weeks, sometimes combined with drainage procedures if
necessary.[19]
Management After Stone Passage
Most patients with GSP
will have spontaneous passage of the offending stone into the duodenum,
resulting in resolution of biliary obstruction and normalization of bilirubin.[1][11][13] In
such cases, if there is no evidence of persistent obstruction or cholangitis,
ERCP is not indicated. The focus remains on supportive care and timely
cholecystectomy.[1][11][13]
Comparison with Non-Biliary Acute
Pancreatitis
In non-biliary AP, the
initial management is limited to supportive care as described above, with no
need for ERCP or cholecystectomy. The focus is on identifying and
addressing the underlying cause (e.g., alcohol, hypertriglyceridemia,
drug-induced, or idiopathic) and implementing preventive strategies specific to
that etiology (e.g., alcohol cessation, lipid control).[9][20]
Management Pathway Visual
The following visual
from JAMA Surgery 2024 provides a concise summary of the evaluation and
management pathway for retained gallstones in gallstone pancreatitis,
highlighting the role of laboratory trends, imaging, and the timing of
cholecystectomy and ERCP:
Figure 1. Evaluation and
Management of Retained Gallstones in Gallstone Pancreatitis
Management of Gallstone Pancreatitis: A Review. JAMA
Surg. July 1, 2024.
Content used under license from the JAMA Network® © American
Medical Association
3. Management After Stone Passage:
Recurrence Risk and Long-Term Prevention
After a gallstone has
passed into the duodenum, the acute episode of GSP often resolves, but the risk
of recurrence remains high if the gallbladder is not removed. The
gallbladder continues to harbor stones, and recurrence rates can be as high as
30–40% within one year, with multiple stones and elevated liver enzymes
increasing risk.[21-23]
Cholecystectomy as the Gold Standard
Laparoscopic
cholecystectomy is the definitive intervention for preventing recurrence of
gallstone-related complications, including recurrent pancreatitis, biliary
colic, and cholecystitis. The timing of cholecystectomy is critical;
guidelines from the American College of Gastroenterology and international
consensus recommend early laparoscopic cholecystectomy within 24–48 hours of
clinical stabilization for mild GSP, and within 2–4 weeks after discharge if
not performed during the index admission.[1][11][16-18] For
patients with severe or necrotizing pancreatitis, cholecystectomy should be
delayed until the acute inflammatory process has resolved, typically 6–8 weeks
post-discharge.[19]
Endoscopic Sphincterotomy for
Non-Surgical Candidates
For patients who are
not surgical candidates due to comorbidities or who require delayed
cholecystectomy, endoscopic biliary sphincterotomy (EBS) during the index
admission may be considered to reduce the risk of recurrent biliary
pancreatitis, although this does not prevent other gallstone-related
complications such as cholecystitis.[1][24][25-26] EBS
reduces the risk of recurrent pancreatitis to approximately 1.8–6.7% at one
year, but the risk of other biliary events remains higher than with
cholecystectomy.[24-26]
Pharmacologic and Lifestyle Measures
Medical management with
bile acid therapy (ursodeoxycholic acid, UDCA) is not recommended by current
guidelines for recurrence prevention after GSP, as its efficacy is limited and
recurrence rates remain high.[1][22][27-28] Lifestyle
modifications, including maintaining a healthy weight, avoiding rapid weight
loss, and managing metabolic risk factors, may reduce gallstone formation but
have limited evidence for preventing recurrence after pancreatitis.[22][29-30]
Quantitative Recurrence Data
The RELAPSTONE study
demonstrated that patients with symptomatic gallstone disease who did not
undergo cholecystectomy during the initial admission had a relapse-free
survival of 79% at 3 months, 71% at 6 months, and 63% at 12 months, indicating
a substantial risk of recurrence within the first year.[21] Cholecystectomy
reduces this risk to near zero for recurrent pancreatitis and other biliary
events.[1][18][25]
4. Prognosis, Complications, and
Outcomes: Gallstone-Induced Versus Other Etiologies
The prognosis and
complication profile of GSP differ from other etiologies of AP, with important
implications for management and follow-up.
Severity and Complication Profile
Large-scale
meta-analyses and cohort studies have demonstrated that
hypertriglyceridemia-induced AP is associated with the highest risk of severe
disease, organ failure, and mortality, followed by alcohol-induced AP, with GSP
generally having a more favorable prognosis in terms of severity and mortality.[31-33] Alcohol-induced
AP is more frequently associated with local complications such as pancreatic
pseudocyst formation and necrosis, and has a higher risk of progression to
chronic pancreatitis if alcohol use continues.[32] In
contrast, GSP is uniquely associated with the risk of persistent or recurrent
biliary obstruction, cholangitis, and recurrent pancreatitis if the underlying
gallstone disease is not definitively treated.[1][11][18]
Recurrence and Long-Term Outcomes
GSP is typically an
acute event that can be "cured" by removal of the
gallbladder. If cholecystectomy is not performed, the risk of recurrent AP
is substantial—8% within a median of 40 days after discharge and up to 22% at 5
years.[1][18] In contrast,
alcohol-induced and hypertriglyceridemia-induced AP are associated with higher
rates of severe disease, local complications, and mortality, and require
ongoing management of the underlying risk factors to prevent recurrence.[31-33]
Visualizing the Natural History and
Management
The following visual
from The New England Journal of Medicine 2016 illustrates the time course and
management of acute pancreatitis, including the critical role of
cholecystectomy in preventing recurrence in gallstone-induced cases:
Figure 1. Time Course and
Management of Acute Pancreatitis.
Acute
Pancreatitis. N Engl J Med. November 17, 2016.
5. Follow-Up, Monitoring, and
Adjunctive Therapies After Discharge
Post-Discharge Follow-Up
After discharge, the
primary focus is on ensuring timely cholecystectomy to prevent
recurrence. For mild GSP, same-admission cholecystectomy within 24–48
hours of clinical stabilization is preferred. If cholecystectomy is not
performed during the index admission, surgery should be scheduled within 2–4
weeks after discharge. In cases of moderately severe or severe
pancreatitis, cholecystectomy should be delayed until resolution of
inflammation and peripancreatic collections, typically 6–8 weeks post-discharge.[1][16][19]
Routine laboratory or
imaging surveillance is not required after cholecystectomy unless symptoms
recur. Patients should be educated on recognizing symptoms of recurrent
biliary events and advised to seek prompt evaluation if symptoms develop.[1][11][17]
Adjunctive and Emerging Therapies
For patients who are
not surgical candidates, endoscopic biliary sphincterotomy is the most
effective and guideline-endorsed adjunctive therapy for recurrence prevention,
reducing the risk of recurrent pancreatitis to approximately 1.8–6.7% at one
year.[1][24-26] Pharmacologic
therapies such as UDCA are not recommended by current guidelines for this
indication, and other endoscopic interventions lack sufficient evidence for
routine use.[1][34]
Noninvasive Imaging for Retained
Stones
The use of noninvasive
imaging (MRCP or EUS) to rule out retained CBD stones after stone passage is
reserved for patients at moderate risk for retained stones—those with equivocal
laboratory or imaging findings, but without clear evidence of cholangitis or
persistent obstruction. EUS has a pooled sensitivity of 96% and
specificity of 92%, while MRCP has a sensitivity of 85% and specificity of 90%.[35-36] EUS
is preferred in patients with risk factors for false-negative MRCP (history of
cholecystectomy, older age, male sex).[37] Imaging
should be performed within two days of any planned ERCP or surgery to maximize
diagnostic yield.[38] Routine
use of MRCP or EUS in all patients after stone passage is not recommended, as
it may delay definitive care and increase costs without improving outcomes.[1][11][39]
Summary and Actionable
Recommendations
In adults without
comorbidities, gallstone-induced acute pancreatitis is distinguished from other
etiologies by a combination of demographic factors (older age, female sex),
clinical history (prior biliary colic or known gallstones), and, most
importantly, laboratory and imaging findings (ALT >150 U/L, elevated
bilirubin, gallstones/sludge on imaging). The initial management of GSP is
characterized by supportive care, assessment for persistent biliary obstruction
or cholangitis (with ERCP reserved for these indications), and definitive
source control via cholecystectomy during the index admission for mild
cases. After a gallstone has passed into the duodenum, ERCP is not
indicated unless there is evidence of ongoing obstruction or cholangitis;
cholecystectomy remains essential to prevent recurrence.
The risk of recurrence
without cholecystectomy is high (up to 30–40% at one year), and cholecystectomy
is the gold standard for recurrence prevention. Endoscopic sphincterotomy
is the best alternative if surgery is contraindicated, reducing the risk of
recurrent pancreatitis to approximately 1.8–6.7% at one year, but does not
prevent all biliary events. Prognosis is generally favorable for GSP if
cholecystectomy is performed, as this effectively eliminates the risk of
recurrence and biliary complications. In contrast, alcohol- and
hypertriglyceridemia-induced AP are associated with higher rates of severe
disease, local complications, and mortality, and require ongoing management of
the underlying risk factors to prevent recurrence.
Routine follow-up after
discharge focuses on ensuring timely cholecystectomy, clinical monitoring for
recurrence, and patient education. Routine laboratory or imaging
surveillance is not required post-cholecystectomy unless symptoms
recur. Noninvasive imaging (MRCP or EUS) to rule out retained CBD stones
is reserved for patients at moderate risk, with EUS preferred in certain
populations. Pharmacologic therapies such as UDCA are not recommended for
recurrence prevention in this context.
